Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Association between negative cognitive bias and depression: A symptom-level approach.

Beevers CG, Mullarkey MC, Dainer-Best J, Stewart RA, Labrada J, Allen JJB, McGeary JE, Shumake J.

J Abnorm Psychol. 2019 Jan 17. doi: 10.1037/abn0000405. [Epub ahead of print]

PMID:
30652884
2.

Using Network Analysis to Identify Central Symptoms of Adolescent Depression.

Mullarkey MC, Marchetti I, Beevers CG.

J Clin Child Adolesc Psychol. 2018 Mar 13:1-13. doi: 10.1080/15374416.2018.1437735. [Epub ahead of print]

PMID:
29533089
3.

Making Friends With Yourself: A Mixed Methods Pilot Study of a Mindful Self-Compassion Program for Adolescents.

Bluth K, Gaylord SA, Campo RA, Mullarkey MC, Hobbs L.

Mindfulness (N Y). 2016 Mar 1;7(2):479-492. Epub 2015 Dec 19.

4.

A School-Based Mindfulness Pilot Study for Ethnically Diverse At-Risk Adolescents.

Bluth K, Campo RA, Pruteanu-Malinici S, Reams A, Mullarkey M, Broderick PC.

Mindfulness (N Y). 2016 Feb;7(1):90-104. Epub 2015 Jan 4. No abstract available.

5.

Distributed acoustic cues for caller identity in macaque vocalization.

Fukushima M, Doyle AM, Mullarkey MP, Mishkin M, Averbeck BB.

R Soc Open Sci. 2015 Dec 23;2(12):150432. doi: 10.1098/rsos.150432. eCollection 2015 Dec.

6.

Intrinsic Connections of the Core Auditory Cortical Regions and Rostral Supratemporal Plane in the Macaque Monkey.

Scott BH, Leccese PA, Saleem KS, Kikuchi Y, Mullarkey MP, Fukushima M, Mishkin M, Saunders RC.

Cereb Cortex. 2017 Jan 1;27(1):809-840. doi: 10.1093/cercor/bhv277.

7.

An electrocorticographic electrode array for simultaneous recording from medial, lateral, and intrasulcal surface of the cortex in macaque monkeys.

Fukushima M, Saunders RC, Mullarkey M, Doyle AM, Mishkin M, Fujii N.

J Neurosci Methods. 2014 Aug 15;233:155-65. doi: 10.1016/j.jneumeth.2014.06.022. Epub 2014 Jun 24. Erratum in: J Neurosci Methods. 2015 Apr 30;245:205-6.

8.

Subcortical white matter abnormalities because of previously undescribed de-novo 14q12-q13.1 triplication.

Rea G, Stallings RL, Mullarkey M, McKinstry CS, McManus D, Morrison PJ.

Clin Dysmorphol. 2013 Apr;22(2):71-2. doi: 10.1097/MCD.0b013e32835f7465. No abstract available.

PMID:
23448906
9.

Trust between nursing management and staff in critical care: a literature review.

Mullarkey M, Duffy A, Timmins F.

Nurs Crit Care. 2011 Mar-Apr;16(2):85-91. doi: 10.1111/j.1478-5153.2010.00404.x. Review.

PMID:
21299761
10.

Agenesis of the corpus callosum with midline lipoma associated with an Xp22.31-Xp22.12 deletion.

Baker LB, Conroy J, Donoghue V, Mullarkey M, Shah N, Murphy N, Murphy J, Ennis S, Lynch SA.

Clin Dysmorphol. 2011 Jan;20(1):21-5. doi: 10.1097/MCD.0b013e32834116f4. No abstract available.

PMID:
21139457
11.

DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1.

Martin SA, McCabe N, Mullarkey M, Cummins R, Burgess DJ, Nakabeppu Y, Oka S, Kay E, Lord CJ, Ashworth A.

Cancer Cell. 2010 Mar 16;17(3):235-48. doi: 10.1016/j.ccr.2009.12.046.

12.

Quantitative cell signalling analysis reveals down-regulation of MAPK pathway activation in colorectal cancer.

Gulmann C, Sheehan KM, Conroy RM, Wulfkuhle JD, Espina V, Mullarkey MJ, Kay EW, Liotta LA, Petricoin EF 3rd.

J Pathol. 2009 Aug;218(4):514-9. doi: 10.1002/path.2561.

PMID:
19396842
13.

Fine mapping and association studies in a candidate region for autism on chromosome 2q31-q32.

Conroy J, Cochrane L, Anney RJ, Sutcliffe JS, Carthy P, Dunlop A, Mullarkey M, O'hici B, Green AJ, Ennis S, Gill M, Gallagher L.

Am J Med Genet B Neuropsychiatr Genet. 2009 Jun 5;150B(4):535-44. doi: 10.1002/ajmg.b.30854.

PMID:
18846500
14.

Antenatal diagnosis of deletion chromosome 11(q23-qter) (Jacobsen syndrome).

Foley P, McAuliffe F, Mullarkey M, Reardon W.

Clin Dysmorphol. 2007 Jul;16(3):177-9.

PMID:
17551332
15.

Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerism.

Nelson JL, Gillespie KM, Lambert NC, Stevens AM, Loubiere LS, Rutledge JC, Leisenring WM, Erickson TD, Yan Z, Mullarkey ME, Boespflug ND, Bingley PJ, Gale EA.

Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1637-42. Epub 2007 Jan 23.

16.

Human leukocyte antigen class II alleles in Caucasian women with primary biliary cirrhosis.

Mullarkey ME, Stevens AM, McDonnell WM, Loubière LS, Brackensick JA, Pang JM, Porter AJ, Galloway DA, Nelson JL.

Tissue Antigens. 2005 Feb;65(2):199-205.

PMID:
15713222
17.

HLA allelic variants encoding DR11 in diffuse and limited systemic sclerosis in Caucasian women.

Loubière LS, Lambert NC, Madeleine MM, Porter AJ, Mullarkey ME, Pang JM, Galloway DA, Furst DE, Nelson JL.

Rheumatology (Oxford). 2005 Mar;44(3):318-22. Epub 2004 Nov 30. Erratum in: Rheumatology (Oxford). 2005 Apr;44(4):569.

PMID:
15572392
18.

Liver biopsies from human females contain male hepatocytes in the absence of transplantation.

Stevens AM, McDonnell WM, Mullarkey ME, Pang JM, Leisenring W, Nelson JL.

Lab Invest. 2004 Dec;84(12):1603-9.

19.

Molecular cytogenetic analysis of recurrent unbalanced t(11;17) in neuroblastoma.

Stallings RL, Carty P, McArdle L, Mullarkey M, McDermott M, Breatnach F, O'Meara A.

Cancer Genet Cytogenet. 2004 Oct 1;154(1):44-51.

PMID:
15381371
20.

Evolution of unbalanced gain of distal chromosome 2p in neuroblastoma.

Stallings RL, Carty P, McArdle L, Mullarkey M, McDermott M, O'Meara A, Ryan E, Catchpoole D, Breatnach F.

Cytogenet Genome Res. 2004;106(1):49-54.

PMID:
15218241
21.

Are gains of chromosomal regions 7q and 11p important abnormalities in neuroblastoma?

Stallings RL, Howard J, Dunlop A, Mullarkey M, McDermott M, Breatnach F, O'Meara A.

Cancer Genet Cytogenet. 2003 Jan 15;140(2):133-7.

PMID:
12645651
22.

Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.

Mullarkey M, Rose JR, Bristol J, Kawata T, Kimura A, Kobayashi S, Przetak M, Chow J, Gusovsky F, Christ WJ, Rossignol DP.

J Pharmacol Exp Ther. 2003 Mar;304(3):1093-102.

PMID:
12604686
23.

Genetic abnormalities in a pre and post-chemotherapy hepatoblastoma.

Mullarkey M, Breen CJ, McDermott M, O'Meara A, Stallings RL.

Cytogenet Cell Genet. 2001;95(1-2):9-11.

PMID:
11978962
24.

A novel class of endotoxin receptor agonists with simplified structure, toll-like receptor 4-dependent immunostimulatory action, and adjuvant activity.

Hawkins LD, Ishizaka ST, McGuinness P, Zhang H, Gavin W, DeCosta B, Meng Z, Yang H, Mullarkey M, Young DW, Yang H, Rossignol DP, Nault A, Rose J, Przetak M, Chow JC, Gusovsky F.

J Pharmacol Exp Ther. 2002 Feb;300(2):655-61.

PMID:
11805229
25.

Isolation and analysis of thermotolerant mutants of wheat.

Mullarkey M, Jones P.

J Exp Bot. 2000 Jan;51(342):139-46.

PMID:
10938805
26.

Coordinate deletion of chromosome 3p and 11q in neuroblastoma detected by comparative genomic hybridization.

Breen CJ, O'Meara A, McDermott M, Mullarkey M, Stallings RL.

Cancer Genet Cytogenet. 2000 Jul 1;120(1):44-9.

PMID:
10913676
27.

Consequences of interaction of a lipophilic endotoxin antagonist with plasma lipoproteins.

Rose JR, Mullarkey MA, Christ WJ, Hawkins LD, Lynn M, Kishi Y, Wasan KM, Peteherych K, Rossignol DP.

Antimicrob Agents Chemother. 2000 Mar;44(3):504-10.

28.

Methotrexate revisited.

Mullarkey MF.

Chest. 1997 Jul;112(1):1-3. No abstract available.

PMID:
9228344
29.

Chromosome deletion 17p11.2 (Smith-Magenis syndrome) in seven new patients, four of whom had been referred for fragile-X investigation.

Behjati F, Mullarkey M, Bergbaum A, Berry AC, Docherty Z.

Clin Genet. 1997 Jan;51(1):71-4.

PMID:
9084941
30.

A comparative study of the clinical efficacy of nedocromil sodium and placebo. How does cromolyn sodium compare as an active control treatment?

Schwartz HJ, Blumenthal M, Brady R, Braun S, Lockey R, Myers D, Mansfield L, Mullarkey M, Owens G, Ratner P, Repsher L, van As A.

Chest. 1996 Apr;109(4):945-52.

PMID:
8635375
31.

Double trisomies.

Seller MJ, Mullarkey M, Daker MG.

Clin Dysmorphol. 1995 Oct;4(4):364-5. No abstract available.

PMID:
8574429
32.

Detection of micro-organisms in the environment.

Powell R, Mullarkey M, O'Brien D, McInerney JO.

Biochem Soc Trans. 1995 May;23(2):435-7. Review. No abstract available.

PMID:
7672437
33.

E5531, a pure endotoxin antagonist of high potency.

Christ WJ, Asano O, Robidoux AL, Perez M, Wang Y, Dubuc GR, Gavin WE, Hawkins LD, McGuinness PD, Mullarkey MA, et al.

Science. 1995 Apr 7;268(5207):80-3.

PMID:
7701344
34.

Immunosuppressive therapy for asthma.

Mullarkey M.

Allergy Proc. 1995 Mar-Apr;16(2):81-4. Review.

PMID:
7797064
35.

Human cutaneous allergic late-phase response is inhibited by soluble IL-1 receptor.

Mullarkey MF, Leiferman KM, Peters MS, Caro I, Roux ER, Hanna RK, Rubin AS, Jacobs CA.

J Immunol. 1994 Feb 15;152(4):2033-41.

PMID:
8120405
36.

Cytogenetic versus DNA diagnosis in routine referrals for fragile X syndrome.

Wang Q, Green E, Barnicoat A, Garrett D, Mullarkey M, Bobrow M, Mathew CG.

Lancet. 1993 Oct 23;342(8878):1025-6.

PMID:
8105267
37.

Complete and partial XY sex reversal associated with terminal deletion of 10q: report of 2 cases and literature review.

Wilkie AO, Campbell FM, Daubeney P, Grant DB, Daniels RJ, Mullarkey M, Affara NA, Fitchett M, Huson SM.

Am J Med Genet. 1993 Jun 15;46(5):597-600. Review.

PMID:
8322827
38.

Use of methotrexate in the treatment of steroid-dependent adolescent asthmatics.

Stempel DA, Lammert J, Mullarkey MF.

Ann Allergy. 1991 Sep;67(3):346-8.

PMID:
1897813
39.

Methotrexate and asthma.

Mullarkey MF.

J Allergy Clin Immunol. 1991 Aug;88(2):272-4. No abstract available.

PMID:
1880327
40.

Long-term methotrexate treatment in corticosteroid-dependent asthma.

Mullarkey MF, Lammert JK, Blumenstein BA.

Ann Intern Med. 1990 Apr 15;112(8):577-81.

PMID:
2327677
41.

Eosinophilic nonallergic rhinitis.

Mullarkey MF.

J Allergy Clin Immunol. 1988 Nov;82(5 Pt 2):941-9. Review.

PMID:
3057047
42.

Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study.

Mullarkey MF, Blumenstein BA, Andrade WP, Bailey GA, Olason I, Wetzel CE.

N Engl J Med. 1988 Mar 10;318(10):603-7.

PMID:
3278232
43.

Propagation and characterization of human blood basophils.

Sorensen LS, Mullarkey MF, Bean MA, Mochizuki DY, Chi EY, Henderson WR.

Int Arch Allergy Appl Immunol. 1988;86(3):267-80.

PMID:
2456992
44.

Methotrexate in the treatment of steroid-dependent asthma.

Mullarkey MF, Webb DR, Pardee NE.

Ann Allergy. 1986 Apr;56(4):347-50.

PMID:
3963528
45.

Association of aspirin-sensitive asthma with HLA-DQw2.

Mullarkey MF, Thomas PS, Hansen JA, Webb DR, Nisperos B.

Am Rev Respir Dis. 1986 Feb;133(2):261-3.

PMID:
3456217
46.

A clinical approach to rhinitis.

Mullarkey MF.

Med Clin North Am. 1981 Sep;65(5):977-86. Review. No abstract available.

PMID:
6116853
47.

The classification of nasal disease: an opinion.

Mullarkey MF.

J Allergy Clin Immunol. 1981 Apr;67(4):251-2. No abstract available.

PMID:
7204782
48.

Effects of corticosteroids on eosinophil chemotaxis and adherence.

Altman LC, Hill JS, Hairfield WM, Mullarkey MF.

J Clin Invest. 1981 Jan;67(1):28-36.

49.

Adverse reactions to radiographic contrast material.

Bush WH Jr, Mullarkey MF, Webb DR.

West J Med. 1980 Feb;132(2):95-8.

50.

Allergic and nonallergic rhinitis: their characterization with attention to the meaning of nasal eosinophilia.

Mullarkey MF, Hill JS, Webb DR.

J Allergy Clin Immunol. 1980 Feb;65(2):122-6.

PMID:
6101336

Supplemental Content

Loading ...
Support Center